# UW Medicine - University of Washington – FDA Inspection, Oct 26, 2011

Source: https://www.keypedia.com/records/fda_inspections/uw-medicine-university-of-washington/6e171695-408d-4974-bdb6-550391540318
Source feed: FDA_Inspections

> FDA inspection 752521 of UW Medicine - University of Washington, October 26, 2011. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 752521
- Company Name: UW Medicine - University of Washington
- Inspection Date: 2011-10-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1230958 - 2024-02-16
- FDA Inspection 1078571 - 2018-12-19
- FDA Inspection 986183 - 2016-09-12
- FDA Inspection 978908 - 2016-06-24
- [FDA Inspection 857674 - 2013-12-05](https://www.keypedia.com/records/fda_inspections/uw-medicine-university-of-washington/82db2230-dc9e-48b2-8c45-cf6c337396fe)

Company: https://www.keypedia.com/companies/uw-medicine-university-of-washington/1eaa54d7-0db5-4636-b54e-4cb8e43a509d

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d